The wire — 11 July 2026

Five rounds from 8–11 July that slipped past this week's daily briefs — a Saturday catchup with no single thread connecting them. They span ultra-low-power chip design, multi-chip AI inference, at-home molecular diagnostics, EU Digital Identity Wallet integration, and fermentation CO2 capture. Worth parsing separately.

The two largest rounds both address different layers of what AI-era infrastructure actually runs on. Belgium's e-peas (Louvain-la-Neuve) raises €19.2 million ($22 million) in a round led by Crédit Mutuel Innovation alongside SFPIM and a broad existing syndicate. e-peas designs ultra-low-power energy-harvesting ICs — the chips that let IoT sensors run without batteries by drawing from ambient light, RF, or vibration. The investor lead is unusual for a deeptech semiconductor company: Crédit Mutuel's natural territory is B2B software. Its presence here, through two entities and at scale, signals commercial traction beyond the research stage. The round funds international expansion and a product portfolio extension into processing and sensing — three ambitions in parallel, with the 18-month test being a tier-one OEM design win.

Paris's ZML raises €17.5 million (approximately $20 million) from 20VC, Kima Ventures, Kindred Ventures, Puzzle Ventures, and AAL Management, with no lead named. ZML builds LLMD, an open-source inference server that runs the same LLM workload across Nvidia CUDA, AMD ROCm, Google TPU, Apple Metal, and Intel Arc through a single interface. The enterprise lock-in problem ZML is solving is real — most production AI deployments are trapped in the Nvidia CUDA ecosystem not by choice but by switching cost — and the investor mix reaches across the Atlantic. The competitive risk is substantial: vLLM, llama.cpp, and Ollama are established alternatives. ZML's claim is an architecture designed for production-grade multi-chip scheduling from the start; the test is whether it translates into distribution.

En Carta Diagnostics (Paris, founded 2022 by Guillaume Horreard and Margot Karlikow) closes a €5 million Seed first close led by Blue Forest Ventures, with Ring Capital, CentraleSupélec Venture, 50 Partners Health, and Bpifrance contributing €2 million in non-dilutive co-financing. En Carta is building at-home molecular tests for Lyme disease — not lateral-flow antibody strips, but full PCR-grade molecular amplification in a consumer format. The technical case is that PCR-level sensitivity catches early Lyme infections that antibody tests miss; the commercial case is that a home format compresses the diagnostic journey. The regulatory path is long and CE-IVD requirements for molecular diagnostics are strict; the first closing funds the validation studies.

Frankfurt's Lissi raises €3.5 million led by Ventech, with BMH, main incubator (Commerzbank Group), and Ninepoint Five Ventures. Lissi builds the integration layer between EU Digital Identity Wallets and bank IT stacks — the middleware that lets financial institutions comply with the AMLR regulation coming into force in July 2027. The company spun out of Commerzbank in 2023 and has built from inside the IT architecture it is now selling into. Ventech backed both Lissi and Naaia in the same week — a consistent bet on regulatory infrastructure with a hard enforcement date.

Bordeaux's W Platform closes the week with a €1 million Seed backed by VitiRev Innovation, Demea Sustainable Investment, and Tudigo. The product is CO2 capture and circular valorisation for wine châteaux and breweries: fermentation releases large volumes of food-grade CO2 that goes into the atmosphere by default; W Platform's systems capture it and route it back on-site for carbonation, inertage, or greenhouse injection. VitiRev's lead is a sector-credibility signal. The €1 million is compact for a hardware-in-a-building deployment model; the 18-month test is unit economics proven at enough sites to justify a follow-on.

e-peas (Louvain-la-Neuve, €19.2M / $22M, Crédit Mutuel Innovation). ZML (Paris, €17.5M / ~$20M, no named lead). En Carta Diagnostics (Paris, €5M Seed first close, Blue Forest Ventures). Lissi (Frankfurt, €3.5M, Ventech). W Platform (Bordeaux, €1M Seed, VitiRev Innovation).